Key facts
- Notable investors include Able Partners.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Bevimi
- ·The full record, as it builds
Funding rounds
No funding rounds for Bevimi are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Bevimi
Developer of cognitive health and wellness solutions intended to address neuroinflammation and support cognitive performance across multiple indications. The company integrates multi-ingredient nutritional formulations, diagnostics, biomarkers, education, and AI-driven insights, enabling individuals seeking preventative brain health support to access science-based nutritional products, personalized recommendations, and educational resources for improved cognitive outcomes, including focus, mood, sleep, and mental acuity.
- Sector
- Healthcare
- HQ
- Greenwich, CT, United States
- Founded
- 2025
- Employees
- 9
- Website
- mybevimi.com/
- Ownership
- Privately Held (backing)
Bevimi doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Bevimi shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Bevimi in its N-PORT filings yet. We sweep new filings monthly.